We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

LiMAx Test Shows Reversibility of Fatty Liver Disease After Obesity Surgery

News   Sep 15, 2015

 
LiMAx Test Shows Reversibility of Fatty Liver Disease After Obesity Surgery
 
 
Advertisement
 

RELATED ARTICLES

FDA Approves Remdesivir for COVID-19

News

The US Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients (≥ 12 years of age and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization.

READ MORE

On-the-Spot Coronavirus Test Within Spitting Distance

News

Mass testing that is fast, non-invasive and able to identify cases before people show symptoms holds the key to boosting COVID-19 detection, improving contact tracing and managing disease outbreaks.

READ MORE

A Potential Diagnostic Test and Molecular Target for Machado-Joseph Disease

News

Researchers have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3), a disease that currently has no cure. The team has also have uncovered the role of a gene target linked to the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE